According to these data, the measurement of PCT levels may also be very helpful as a biomarker in the setting of relapsed/refractory HL, where patients are frequently febrile and undergo aggressive chemotherapy with prolonged neutropenia, thus being exposed to an increased risk of infection. The gene discussed is CALCA; the disease is infection.